Masking Cationic Charges to Fight Malaria

  • ChemPubSoc Europe Logo
  • Author: Melania Tesio
  • Published Date: 06 July 2012
  • Source / Publisher: ChemMedChem/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Masking Cationic Charges to Fight Malaria

Related Societies

Bis-alkylamidines compounds, bioisosteres of bis-thiazolium salts, are potent antimalaric drugs developed to fight multidrug resistant strains of the parasite Plasmodium. These drugs interfere efficiently with the parasite's phosphatidylcholine biosynthesis by acting as choline analogs. But they can be administered only parenterally as their cationic charges prevent a good oral bioavailability.

In order to circumvent this problem and mask the charges, Mélissa Degardin and colleagues, Université de Montpellier, France, used a prodrug strategy consisting of sulfonate derivatives of bis-alkylamidoximes.

The team synthetized 25 new sulfonates and demonstrated that O-alkylsulfonate derivatives possess the best oral antimalaric activity. The alkyl substituent on the sulfonate group likely affects the lipophilicity of the compunds and their ability to diffuse through cellular membranes, two parameters influencing oral absorption.

Directly converted into their corresponding active alkylamidines, bis-alkylamidoxime O-alkylsulfonates could be therefore promising oral antimalaric drugs.

Article Views: 1956

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH